Stay updated on Sotorasib in KRAS p.G12C+ Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Sotorasib in KRAS p.G12C+ Solid Tumors Clinical Trial page.

Latest updates to the Sotorasib in KRAS p.G12C+ Solid Tumors Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedRevision: v3.4.2 was added, replacing the previous v3.4.1 label on the history page.SummaryDifference0.0%

- Check20 days agoChange DetectedRevision updated from v3.4.0 to v3.4.1; no substantive changes to study content or page layout are visible.SummaryDifference0.0%

- Check27 days agoChange DetectedGlossary toggle is now shown, and changes are indicated with green for additions and red for deletions. The revision tag updated to v3.4.0 and capitalization of No FEAR Act data was standardized.SummaryDifference0.4%

- Check42 days agoChange DetectedRevision: v3.3.4 was added and Revision: v3.3.3 was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check63 days agoChange DetectedA new revision entry 'Revision: v3.3.3' was added, and the 'HHS Vulnerability Disclosure' link and the older 'Revision: v3.3.2' entry were removed.SummaryDifference0.1%

- Check92 days agoChange DetectedThe only observed change is the site revision update from v3.2.0 to v3.3.2 in the footer; no study data or page content was altered. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Sotorasib in KRAS p.G12C+ Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Sotorasib in KRAS p.G12C+ Solid Tumors Clinical Trial page.